Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Lupus|April 11, 2017
Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patientsC C M Valões, B C Molinari, A C G Pitta, et al.
Advances in Rheumatology (London, England)|January 19, 2019
Autoimmune hepatitis in 847 childhood-onset systemic lupus erythematosus population: a multicentric cohort studyVerena A Balbi, Bárbara Montenegro, Ana C Pitta, et al.
Pediatric Cardiology|November 10, 2016
Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease ManifestationsPedro Anuardo, Monica Verdier, Natali W S Gormezano, et al.
The American Journal of Clinical Nutrition|May 21, 2021
Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort studyBruna Z Reis, Alan L Fernandes, Lucas P Sales, et al.
International Journal of Obesity (2005)|December 30, 2022
Exercise modifies hypothalamic connectivity and brain functional networks in women after bariatric surgery: a randomized clinical trialCarlos A A Merege-Filho, Saulo S Gil, John P Kirwan, et al.
Lupus|January 31, 2017
Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groupsS R M Lopes, N W S Gormezano, R C Gomes, et al.
Rheumatology (Oxford, England)|May 31, 2022
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccineNadia E Aikawa, Leonard V K Kupa, Clovis A Silva, et al.
Revista Brasileira De Reumatologia|August 26, 2017
Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosisSebastião Cézar Radominski, Wanderley Bernardo, Ana Patrícia de Paula, et al.
Clinical Rheumatology|June 14, 2022
COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditionsBianca P Ihara, Lívia M Lindoso, Debora N D Setoue, et al.
The Lancet. Rheumatology|December 13, 2021
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective studyNadia E Aikawa, Leonard V K Kupa, Sandra G Pasoto, et al.
Pageof 26